Erasmus MC Transplant Institute, Department of Surgery, Division of HPB & Transplant Surgery, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015GD, Rotterdam, Netherlands.
Erasmus MC Transplant Institute, Department of Surgery, Division of HPB & Transplant Surgery, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015GD, Rotterdam, Netherlands.
HPB (Oxford). 2023 Aug;25(8):863-871. doi: 10.1016/j.hpb.2023.03.006. Epub 2023 Mar 9.
To this day, a discrepancy exists between donor liver demand and supply. Domino liver transplantation (DLT) can contribute to increasing the number of donor livers available for transplantation.
The design of this systematic review was based on the Preferred Reporting Items for Systematic Reviews (PRISMA). A qualitative analysis of included studies was performed. Primary outcomes were mortality and peri- and postoperative complications related to DLT.
Twelve studies met the inclusion criteria. All included studies showed that DLT outcomes were comparable to outcomes of deceased donor liver transplantation (DDLT) in terms of mortality and complications. One-year patient survival rate ranged from 66.7% to 100%. Re-transplantation rate varied from 0 to 12.5%. Most frequent complications were related to biliary (3.7%-37.5%), hepatic artery (1.6%-9.1%), portal vein (12.5-33.3%) and hepatic vein events (1.6%), recurrence of domino donor disease (3.3%-17.4%) and graft rejection (16.7%-37.7%). The quality of the evidence was rated as moderate according to the Newcastle-Ottawa scale (NOS).
DLT outcomes were similar to DDLT in terms of mortality and complications. Even though DLT will not solve the entire problem of organ shortage, transplant programs should always consider using this tool to maximize the availability of liver grafts.
时至今日,供肝需求与供体之间仍存在差距。多米诺肝移植(DLT)有助于增加可用于移植的供肝数量。
本系统评价的设计基于系统评价的首选报告项目(PRISMA)。对纳入的研究进行定性分析。主要结局是与 DLT 相关的死亡率和围手术期并发症。
符合纳入标准的研究共有 12 项。所有纳入的研究表明,在死亡率和并发症方面,DLT 结果与已故供体肝移植(DDLT)的结果相当。1 年患者生存率为 66.7%至 100%。再移植率从 0 到 12.5%不等。最常见的并发症与胆道(3.7%-37.5%)、肝动脉(1.6%-9.1%)、门静脉(12.5-33.3%)和肝静脉事件(1.6%)、多米诺供体疾病的复发(3.3%-17.4%)和移植物排斥(16.7%-37.7%)有关。根据纽卡斯尔-渥太华量表(NOS),证据质量评为中等。
在死亡率和并发症方面,DLT 结果与 DDLT 相似。尽管 DLT 并不能解决器官短缺的全部问题,但移植项目应始终考虑使用该工具来最大限度地增加肝移植物的可用性。